CyrusOne Inc. [NASDAQ:CONE]: Analyst Rating and Earnings

Equities traders oftentimes stay updated on what leading stock market analysts say about a potential stock purchase. When it comes to CyrusOne Inc. [CONE], the most recently available average analyst rating is from the quarter that ends in December. On average, stock market experts give CONE an Outperform rating. The average 12-month price forecast for this stock is $65.26, with the high estimate being $75.00, the low estimate being $50.00 and the median estimate amounting to $68.00. This is compared to its latest closing price of $52.92.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for CyrusOne Inc. [CONE] is sitting at 1.90. This is compared to 1 month ago, when its average rating was 1.90.

For the quarter ending in Sep-18 CyrusOne Inc. [CONE] generated $0.21 billion in sales. That’s 0.97% lower than the average estimate of $0.21 billion as provided by Wall Street analysts. The three indicators above suggest that on the whole, this stock is not presenting an attractive investment option, as there are too many red flags that don’t point to a high-value ROI.

Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Wed 20 Feb (In 41 Days).

Fundamental Analysis of CyrusOne Inc. [CONE]

Now let’s turn to look at profitability: with a current Operating Margin for CyrusOne Inc. [CONE] sitting at +3.85 and its Gross Margin at +26.49, this company’s Net Margin is now 14.00%. These measurements indicate that CyrusOne Inc. [CONE] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

This company’s Return on Total Capital is 0.80, and its Return on Invested Capital has reached -0.40%. Its Return on Equity is -5.87, and its Return on Assets is -2.36. These metrics suggest that this CyrusOne Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organization’s capital structure, CyrusOne Inc. [CONE] has generated a Total Debt to Total Equity ratio of 130.19. Similarly, its Total Debt to Total Capital is 56.56, while its Total Debt to Total Assets stands at 51.75. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 129.67, and its Long-Term Debt to Total Capital is 56.33. This company is not leveraging its assets to take on debt, which stunts its growth and limits the ROI for investors.

What about valuation? This company’s Enterprise Value to EBITDA is 26.27 and its Total Debt to EBITDA Value is 6.32. The Enterprise Value to Sales for this firm is now 9.59, and its Total Debt to Enterprise Value stands at 0.30. CyrusOne Inc. [CONE] has a Price to Book Ratio of 3.34, a Price to Cash Flow Ratio of 18.11 and P/E Ratio of 45.40. These metrics show that this company has a mixed appeal, and ROI could be a gain or a loss.

Shifting the focus to workforce efficiency, CyrusOne Inc. [CONE] earns $1,615,385 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 7.73 and its Total Asset Turnover is 0.19.

Performance Indicators

Let’s now turn our attention to trading performance: CyrusOne Inc. [CONE] has 103.24M shares outstanding, amounting to a total market cap of $5.19B. Its stock price has been found in the range of 43.49 to 69.01. At its current price, it has moved by -27.13% from its 52-week high, and it has moved 15.64% from its 52-week low.

This stock’s Beta value is currently 1.02, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 38.71. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is CyrusOne Inc. [CONE] a Reliable Buy?

CyrusOne Inc. [CONE] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.